Literature DB >> 25975051

Effect of Bushenwenyanghuayu decoction on nerve growth factor and bradykinin/bradykinin B1 receptor in a endometriosis dysmenorrhea mouse model.

Chen Jingwei, Du Huilan, Tong Ruixiao, Yang Hua, Ma Huirong.   

Abstract

OBJECTIVE: To observe the effects of Bushenwenyanghuayu decoction (BD), a Traditional Chinese Medicine (TCM), on the serum concentration of nerve growth factor (NGF) and bradykinin (BK), and protein and mRNA levels of NGF and bradykinin B1 receptor (BKB1R) in a mouse model of endometriosis dysmenorrhea.
METHODS: Seventy-five experimental female BALB/c mice were randomly divided into five groups, 15 mice each: sham, model, BD high dose (61.67 g/kg), BD low dose (15.42 g/kg), and gestrinone (0.4 mg/kg) groups. All the mice except for those in the sham group underwent auto-transplantation surgery and were gavaged estradiol valerate (0.5 mg/kg, daily for 12 days) after surgery. On the 12th day, 1 h after administration, writhing response was induced by intraperitoneal injection of oxytocin at 2 U/mouse. The writhing frequency and latency were recorded and the volume of the ectopic foci was measured. The concentration of serum NGF and BK was detected by enzyme-linked immunosorbent assay, the protein expression of NGF and BKB1R was tested by immunohistochemistry and western blotting, and NGF and BKB1R mRNAs were detected by real-time PCR.
RESULTS: Compared with the model group, the volume of the ectopic foci in the treatment groups was significantly lower (P < 0.01), the writhing frequency was decreased (P < 0.05), and the writhing latency was prolonged (P < 0.01). Compared with the sham group, serum NGF and BK levels in the model group were significantly increased (P < 0.01). There were positive correlations for writhing frequency among the NGF and BK groups (P < 0.01). The serum NGF and BK levels were significantly lower in the treatment groups than the model group (P < 0.05). The protein expression of NGF, BKB1R was significantly decreased in the treatment groups compared with the model group (P < 0.01). NGF and BKB1R mRNA expression was significantly decreased in the treatment groups compared with the model group (P < 0.01).
CONCLUSION: NGF and BK/BKB1R may play an important role in the development of endometriosis-associated dysmenorrhea, and BD was found to inhibit the development of endometriosis and relieve dysmenorrhea by influencing NGF and BK/ BKB1R mRNA and protein levels.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25975051     DOI: 10.1016/s0254-6272(15)30026-1

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  4 in total

1.  Inflammation-mediated macrophage polarization induces TRPV1/TRPA1 heteromers in endometriosis.

Authors:  Hai Zhu; Yi Wang; Yibo He; Weifeng Yu
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

2.  Therapeutic effects of mifepristone combined with Gestrinone on patients with endometriosis.

Authors:  Hui-Ling Xue; Ning Yu; Jing Wang; Wan-Jiao Hao; Ye Li; Mei-Yun Liu
Journal:  Pak J Med Sci       Date:  2016 Sep-Oct       Impact factor: 1.088

3.  The Root Aqueous Extract of Entada africana Guill. et Perr. (Mimosaceae) Inhibits Implant Growth, Alleviates Dysmenorrhea, and Restores Ovarian Dynamic in a Rat Model of Endometriosis.

Authors:  Marie Alfrede Mvondo; Stéphane Minko Essono; Francis Désiré Bomba Tatsinkou; Sylvin Benjamin Ateba; Dieudonné Njamen
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-31       Impact factor: 2.629

4.  Effects of botulinum toxin A on endometriosis‑associated pain and its related mechanism.

Authors:  Fubo Tian; Wuzhong Cheng; Jianying Hu; Shaoqiang Huang; Shen Sun
Journal:  Mol Med Rep       Date:  2020-09-10       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.